SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants

Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose infection in humans causes mild or severe clinical manifestations that mainly affect the respiratory system. So far, the CO...

Full description

Bibliographic Details
Main Authors: Daniel Martínez-Flores, Jesús Zepeda-Cervantes, Adolfo Cruz-Reséndiz, Sergio Aguirre-Sampieri, Alicia Sampieri, Luis Vaca
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
spike glycoprotein
RBD
vaccine design
SARS-CoV-2 variants
resistance to neutralization
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.701501/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.701501/full

Similar Items